Fragmento

Functional dyspepsia is a highly prevalent disease worldwide. Its symptoms are manifested as pain (burning or not) in the upper abdomen and early satiety, postprandial fullness, bloating, nausea and belching. For its study and treatment, it is divided into 2 syndromes: epigastric pain, which is meal unrelated, and postprandial distress, which as the name suggests, are meal related symptoms. These 2 syndromes frequently overlap. The term functional dyspepsia implies a patient with upper digestive symptoms whose endoscopy reveals a normal stomach and duodenum or with minimum changes, the Rome III criteria diagnoses this disease; nevertheless, recent studies suggest the need to modify the temporality criteria. Categorizing patients into 2 syndromes has therapeutic implications, which are based on pathophysiological mechanisms, considering that patients with epigastric pain may have hypersensitivity or a Helicobacter pylori (H. pylori) infection, while patients with postprandial distress may suffer fundic-relaxation or gastric emptying issues. Within the therapeutic approach of functional dyspepsia, there are important pharmacological and non-pharmacological measures.

Palabras clave:

2015-01-28   |   327 visitas   |   Evalua este artículo 0 valoraciones

Vol. 16 Núm.64. Julio-Septiembre 2014 Pags. 146-148 Med Univer 2014; 16(64)